Another Alzheimer Drug Bites the Dust
Another potential blockbuster drug has flopped. Despite this, the feds still have natural alternative treatments in the crosshairs. From Forbes: Investors poured hundreds of millions of dollars into Axovant and its experimental Alzheimer’s drug, intepirdine. But in the end, the medicine was no different from 99% of medicines tested against the brain-wasting disease since 2002 — it […]